Hanns-Christian Mahler, PhD
CEO
ten23 health
Innovation Award Finalist
Development of a Small Molecule, High Viscosity, High PH Injectable for HIV Treatment
Dr. Hanns Mahler is Founder, CEO and Board Member at ten23 health, the human-centric and sustainable partner for sterile product development, manufacturing and testing. He is also adjunct faculty at the Universities of Frankfurt (Germany) and Basel (Switzerland),
serves as Scientific Expert at EDQM and as Board Member for Bionter & KriyaBio. He is also Advisory Board Member for Sustainability at J&J and Advisory Board Member at Nanotemper. He holds a PhD in Toxicology from the University of Mainz.